2160 GNI Group Ltd.ジーエヌアイグループTSE Growth / Pharmaceuticals
0 posts
GNI Group Ltd. (2160) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
GNI Group Ltd. (2160) Stock Price History
GNI Group Ltd. closed at ¥2,089 on Nov 20, 2026, −23.6% over 1 month, −15.1% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥76,380 today (−23.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −23.6%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥2,089 | −114 | −5.17% |
| Nov 19 (Thu) | ¥2,203 | −25 | −1.12% |
| Nov 18 (Wed) | ¥2,228 | −64 | −2.79% |
| Nov 17 (Tue) | ¥2,292 | +26 | +1.15% |
| Nov 16 (Mon) | ¥2,266 | +134 | +6.29% |
| Nov 13 (Fri) | ¥2,132 | +109 | +5.39% |
| Nov 12 (Thu) | ¥2,023 | −117 | −5.47% |
| Nov 11 (Wed) | ¥2,140 | −52 | −2.37% |
| Nov 10 (Tue) | ¥2,192 | +81 | +3.84% |
| Nov 9 (Mon) | ¥2,111 | +38 | +1.83% |
If you had invested ¥100,000 3 months ago, it would be worth ¥70,838 today (−29.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −29.2%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥2,089 | −114 | −5.17% |
| Nov 19 (Thu) | ¥2,203 | −25 | −1.12% |
| Nov 18 (Wed) | ¥2,228 | −64 | −2.79% |
| Nov 17 (Tue) | ¥2,292 | +26 | +1.15% |
| Nov 16 (Mon) | ¥2,266 | +134 | +6.29% |
| Nov 13 (Fri) | ¥2,132 | +109 | +5.39% |
| Nov 12 (Thu) | ¥2,023 | −117 | −5.47% |
| Nov 11 (Wed) | ¥2,140 | −52 | −2.37% |
| Nov 10 (Tue) | ¥2,192 | +81 | +3.84% |
| Nov 9 (Mon) | ¥2,111 | +38 | +1.83% |
If you had invested ¥100,000 6 months ago, it would be worth ¥76,352 today (−23.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −23.6%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥2,089 | −10.2% |
| Oct 2026 | ¥2,325 | −29.1% |
| Sep 2026 | ¥3,280 | +16.6% |
| Aug 2026 | ¥2,813 | +13.7% |
| Jul 2026 | ¥2,475 | −13.1% |
| Jun 2026 | ¥2,848 | +11.9% |
| May 2026 | ¥2,546 | −12.8% |
If you had invested ¥100,000 1 year ago, it would be worth ¥84,919 today (−15.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −15.1%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥2,089 | −10.2% |
| Oct 2026 | ¥2,325 | −29.1% |
| Sep 2026 | ¥3,280 | +16.6% |
| Aug 2026 | ¥2,813 | +13.7% |
| Jul 2026 | ¥2,475 | −13.1% |
| Jun 2026 | ¥2,848 | +11.9% |
| May 2026 | ¥2,546 | −12.8% |
| Apr 2026 | ¥2,920 | −0.7% |
| Mar 2026 | ¥2,940 | −7.0% |
| Feb 2026 | ¥3,160 | +24.0% |
| Jan 2026 | ¥2,548 | +5.6% |
| Dec 2025 | ¥2,412 | −6.1% |
| Nov 2025 | ¥2,569 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥68,046 today (−32.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −32.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,089 | −13.4% |
| 2025 | ¥2,412 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥136,894 today (+36.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved +36.9%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,089 | −13.4% |
| 2025 | ¥2,412 | ― |
If you had invested ¥100,000 in Sep 2007, it would be worth ¥895,287 today (+795.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +236.2%, while this stock moved +795.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,089 | −13.4% |
| 2025 | ¥2,412 | −29.2% |
| 2024 | ¥3,405 | +20.3% |
| 2023 | ¥2,830 | +103.2% |
| 2022 | ¥1,393 | −5.9% |
| 2021 | ¥1,481 | −18.1% |
| 2020 | ¥1,808 | −31.1% |
| 2019 | ¥2,624 | +156.8% |
| 2018 | ¥1,022 | −48.3% |
| 2017 | ¥1,977 | +172.0% |
| 2016 | ¥727 | +14.1% |
| 2015 | ¥637 | −40.5% |
| 2014 | ¥1,070 | −31.3% |
| 2013 | ¥1,557 | +282.8% |
| 2012 | ¥407 | +37.1% |
| 2011 | ¥297 | +206.9% |
| 2010 | ¥96.7 | +3.6% |
| 2009 | ¥93.3 | +211.1% |
| 2008 | ¥30.0 | −88.9% |
| 2007 | ¥270 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Sep 2007). Please check the latest prices before trading.
GNI Group Ltd. (2160) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of GNI Group Ltd. (2160)
Business overview
The company runs two businesses: pharmaceuticals and medical devices. Its pharmaceutical business researches, develops, makes and sells compounds centered on Aisuliyu, sold in the Chinese market, and F351, which has completed clinical trials. Its medical device business, based in the US, develops, makes and sells medical devices such as biomaterials, and in Japan it also makes dental prostheses. The group has 24 consolidated subsidiaries and two affiliates.
Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 2.88x | Above the sector median of 1.86x (No. 57 from the lowest) |
|---|---|---|
| Market cap | ¥116.6 bn | No. 23 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥3,685 | 3/11 |
|---|---|---|
| 52-week low | ¥2,023 | 11/12 |
| Current position | 4.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥2,089) |
| Year to date | -13.4% | No. 40 of 77 in the sector (best first) |
| 1 year | -15.1% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 4 times | Latest: 11/2 (No. 36) |
|---|---|---|
| Top 50 losers | 5 times | Latest: 11/6 (No. 31) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/19 16:00Jefferies Global Healthcare Conferenceにおける機関投資家からのご質問および回答について
- 11/13 16:302026年12月期 第3四半期 決算短信〔IFRS〕(連結)
- 11/13 16:302026年12月期 第3四半期決算説明資料
- 11/06 08:50当社子会社Gyre Therapeuticsによる2026年度第3四半期決算およびF351の新薬承認審査の進捗について
- 10/07 17:00グロース市場からTOPIXへ――ジーエヌアイグループ、制度改革後初の定期入替で新規採用
Filings from the past 12 months (5).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.